knowledge -WSS

knowledge

author：leisure time 2025-09-27 23:03:11 - browse：2112

Humana sign -- health business coverage from STAT — Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Phenylephrine and the overlooked value of the placebo effect

Wikipedia

WSS

Gene therapy’s promise and the high cost of hope

Physician executives need more than on

Travis Kelce and the trap of celebrity vaccine endorsements

Why age limits for politicians are a terrible idea

Bristol 'take

Why Charlie Gard's case is so disturbing to Americans

hotspot

knowledge

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Kidney transplant patients stopped immunosuppressants in trial

Supreme Court strikes down use of affirmative action

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

In age of alternative facts, a scholarly course on calling out crap

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Supreme Court strikes down use of affirmative action

How neuroscience research could help beat back brain cancer

Supreme Court strikes down use of affirmative action

Bill would stop addiction treatment from triggering child abuse inquiry

entertainment

Explaining an after

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Bill would allow buprenorphine prescription for addiction via telehealth

Sana to lay off nearly a third of staff, de

Colorectal cancer study finds potential in overlooked immune cell

Why Charlie Gard's case is so disturbing to Americans

knowledge

explore

Wikipedia

Wikipedia